Description
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Product Unit Size | Cost | Quantity | Stock |
---|
Sotorasib is a inhibitor of KRASG12C, which is a notoriously difficult to treat cancerous mutation.
Cas No. | 2296729-00-3 |
---|---|
Purity | ≥99% |
Formula | C30H30F2N6O3 |
Formula Wt. | 560.61 |
IUPAC Name | (1R)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-pyrido[2,3-d]pyrimidin-2(1H)-one |
Synonym | AMG-510 |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zheng X, Luo J, Liu W, et al. Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12c mutation. Drugs Today (Barc). 2022 Apr;58(4):175-185. PMID: 35412531
Werner J, Davies R, Wahlstrom J, et al. Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12c, are associated with renal toxicity in the Sprague Dawley rat. Toxicol Appl Pharmacol. 2021 Jul 15;423:115578. PMID: 34004237
Koga T, Suda K, Fujino T, et al. KRAS secondary mutations that confer acquired resistance to KRAS G12c inhibitors, sotorasib and adagrasib, and overcoming strategies: insights from in vitro experiments. J Thorac Oncol. 2021 Aug;16(8):1321-1332. PMID: 33971321
Aminopropyl carbazole, neuroprotective.
Micronuclei formation inducer, antimitotic, oxi...
DOT1L HMT inhibitor.
Flavonoid found in various plant sources.
Mycotoxin produced by Penicillum, Aspergillus, ...
Endogenous tachykinin peptide, involved in infl...
Furanolactone found in citrus fruits.
Polymer precursor
Docetaxel impurity
D2/3 agonist.
p110δ and p110γ PI3K inhibitor.
Endogenous glycoprotein; lactoferrin agonist.
nNOS inhibitor.
Syk inhibitor.
Imidazoquinazoline; PDE3 inhibitor.
Imidazole; 14-α demethylase inhibitor.
Amphiphilic properties
p110α PI3K inhibitor.
Casein kinase 2 inhibitor.
Flavonoid originally found in Silybum (milk thi...